The Quantitative Structure-Activity Relationships between GABAA Receptor and Ligands based on Binding Interface Characteristic

Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..

BACKGROUND: Quantitative Structure Activity Relationship (QSAR) methods based on machine learning play a vital role in predicting biological effect.

OBJECTIVE: Considering the characteristics of the binding interface between ligands and the inhibitory neurotransmitter Gamma-Aminobutyric Acid A(GABAA) receptor, we built a QSAR model of ligands that bind to the human GABAA receptor.

METHODS: After feature selection with Mean Decrease Impurity, we selected 53 from 1,286 docked ligand molecular descriptors. Three QSAR models are built using a gradient boosting regression tree algorithm based on the different combinations of docked ligand molecular descriptors and ligand receptor interaction characteristics.

RESULTS: The features of the optimal QSAR model contain both the docked ligand molecular descriptors and ligand-receptor interaction characteristics. The Leave-One-Out-Cross-Validation (Q2 LOO) of the optimal QSAR model is 0.8974, the Coefficient of Determination (R2) for the testing set is 0.9261, the Mean Square Error (MSE) is 0.1862. We also used this model to predict the pIC50 of two new ligands, the differences between the predicted and experimental pIC50 are -0.02 and 0.03, respectively.

CONCLUSION: We found the BELm2, BELe2, MATS1m, X5v, Mor08v, and Mor29m are crucial features, which can help to build the QSAR model more accurately.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:17

Enthalten in:

Current computer-aided drug design - 17(2021), 6 vom: 31., Seite 785-796

Sprache:

Englisch

Beteiligte Personen:

Cheng, Shu [VerfasserIn]
Ding, Yanrui [VerfasserIn]

Links:

Volltext

Themen:

GABAA
GBRT
Journal Article
Ligand-receptor interaction characteristics
Ligands
Mean decrease impurity
PIC50
QSAR
Random forests
Receptors, GABA-A

Anmerkungen:

Date Completed 13.01.2022

Date Revised 13.01.2022

published: Print

Citation Status MEDLINE

doi:

10.2174/1573409916666200724153240

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM312892713